Loading organizations...
Meltwind Advisory is a venture capital firm based in Cambridge, United Kingdom, investing in early-stage healthcare and biotechnology companies. The firm provides due diligence and portfolio management for investments in life science tools and platform therapeutics, fostering scientific advancements. It actively engages with its portfolio, building a collaborative environment for growth.
Founded in 2014, Meltwind Advisory was established to manage investment activities for Jonathan Milner, who founded and formerly led Abcam. Milner's extensive life sciences background provides the foundational insight, allowing the firm to channel his expertise and capital into promising nascent ventures within the health and biotech landscape.
The firm serves early-stage health and biotech companies seeking capital and strategic guidance. Meltwind Advisory's vision is to facilitate the transition of scientific research into marketable technologies. It cultivates an ecosystem that propels discoveries from the lab to practical application, contributing to the future of life sciences.
Meltwind has 12 tracked investments across 11 companies. The latest tracked deal is $15.5M Seed in Syndex Bio in February 2026.